B
SAGE

Bailard’s Sage Therapeutics SAGE Stock Holding History

Bailard’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,500
Closed -$275K – 674
2020
Q3 		$275K Buy
+4,500
New +$228K 0.01% 403
2019
Q4 		– Sell
-1,700
Closed -$238K – 602
2019
Q3 		$238K Hold
1,700
– – 0.01% 443
2019
Q2 		$311K Hold
1,700
– – 0.02% 404
2019
Q1 		$270K Buy
+1,700
New +$246K 0.02% 440
2018
Q4 		– Sell
-1,700
Closed -$240K – 546
2018
Q3 		$240K Hold
1,700
– – 0.01% 494
2018
Q2 		$266K Hold
1,700
– – 0.02% 462
2018
Q1 		$274K Hold
1,700
– – 0.02% 426
2017
Q4 		$280K Buy
+1,700
New +$165K 0.02% 382

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return